Brands
Johnson & Johnson Vision’s ACUVUE onboards Ranveer Singh
Mumbai: Johnson & Johnson Vision, a global leader in eye health and part of Johnson & Johnson MedTech, has announced that it has joined hands with Superstar Ranveer Singh to encourage Gen Zers and millennials to try contact lenses. The campaign is aimed at amplifying ACUVUE’s mission to build awareness for eye health and welcome new contact lens wearers.
It focuses on:
- Emphasizing ACUVUE as the #1 selling brand family of contact lenses worldwide*, thereby motivating consumers to try contact lenses
- Encourage consumers to consult an optometrist for an eye check-up and a great first-time contact lens fitting experience
- Introducing small packages at accessible pricing to bust myths about high price points of contact lenses
Over the last few years, ACUVUE has spearheaded the transformation of eye health in India. The brand has adopted effective measures to understand the need of Indian consumers and address their apprehension around the usage of contact lenses. In fact, ACUVUE is relentlessly working towards bridging the gap between consumers and optometrists by increasing awareness around the category and motivating consumers to go for regular eye check-ups.
Consumers often turn to their peers for advice on contact lenses instead of consulting an expert. This campaign is an effort to lead consumers to consult an optometrist, who should be their first port of call for information on contact lenses as well as spread awareness about eye health in a light-hearted and meaningful way. With Ranveer Singh headlining the campaign, we hope to build a strong, committed, and engaging connect with the youth in India.
Talking about the launch, Johnson & Johnson Vision business unit director – vision care India Tiny Sengupta said, “ACUVUE is leading by example and transforming eye health in India by creating awareness around contact lenses. ACUVUE is the #1 selling brand family of contact lenses worldwide, but the contact lens usage is still low in India. We are on a mission to make ACUVUE the No.1 choice of contact lens brand In India.
The campaign intends to build a behavior amongst the youth of going for a regular eye check and asking an expert before trying contact lenses for the first time. We aim to make contact lenses accessible for the consumers and ensure that consumers are equipped with the right set of information about contact lenses, amidst all the surrounding myths and misconceptions about the category.
We are excited to welcome Ranveer Singh onboard, India’s youth icon, and harness his power to expand our reach to a wider audience. His influential voice will be instrumental in connecting with more consumers and spread awareness about the benefits of ACUVUE. His charisma and popularity among the youth will be helpful in building a new generation of well-informed consumers. Through this campaign, we are excited to continue transforming the trajectory of eye health in India.”
Expressing his excitement about the new collaboration, superstar Singh added, “It is an absolute pleasure to join ACUVUE in their journey to lead conversations around eye health in India. This campaign gives me an opportunity to inform the youth on the importance of eye health. I am looking forward to the young consumers to join me in this journey by visiting an optometrist for their first contact lens fitting experience.”
The #AcuvueSePoochho campaign has a humorous touch, leaving the audience with a call to action to visit www.Acuvue.co.in for the right information on contact lenses. Conceptualized by Ogilvy India, #AcuvueSePoochho pioneers the conversations around a reliable source for information on contact lenses and importance of meeting with optometrists for their expert guidance.
Brands
India, Uzbekistan launch pharma and nutraceutical trade corridor
New partnership positions Uzbekistan as gateway to a USD 10 bn Eurasian health market
TASHKENT: India’s pharmaceutical and nutraceutical industries are getting a new route into Eurasia, and it runs through Tashkent.
The ministry of health of the republic of Uzbekistan has partnered with nutrify today and pharma eurasia to launch a structured indo–cis pharmaceutical and nutraceutical trade corridor. The initiative aims to streamline market access for Indian and global companies into the commonwealth of independent states and the wider Eurasian region.
The corridor brings together government policy support, industry leadership and a commercial platform designed to translate high-level discussions into actual trade deals. Pharma Eurasia 2026, scheduled in Tashkent from 20 to 22 May, will serve as the main marketplace where these opportunities are expected to materialise.
The timing is significant. The dietary supplements market across the CIS is already worth more than $ 5.8 billion annually, while the wider Eurasian nutraceutical sector is estimated at $ 7 billion to $ 10 billion and expanding quickly. Demand is being driven by rising interest in preventive healthcare, the spread of organised pharmacy chains and growing consumer appetite for vitamins, botanicals and functional nutrition products.
For Indian exporters, the corridor offers a structured entry point into these markets. The initiative also comes as regulatory systems across several CIS economies are tightening, creating greater demand for quality-certified products.
Uzbekistan is positioning itself as the region’s health industry gateway. In recent years the country has invested heavily in pharmaceutical parks, industrial clusters and regulatory reforms designed to attract foreign investment and manufacturing partnerships. Tashkent’s pharma park is intended to provide overseas pharmaceutical and nutraceutical firms with a clear pathway to establish production or distribution bases with government support.
The new trade corridor operates on what organisers call a dual-city model. Strategic dialogue and industry leadership discussions will take place in Mumbai through the sumflex and c-suite summit platforms, bringing together global CEOs, regulators and investors. The commercial follow-through will happen in Tashkent at pharma eurasia, where partnerships, regulatory engagement and buyer connections are expected to move deals forward.
Pharma Eurasia 2026 is designed as a meeting ground for manufacturers, ingredient suppliers, contract development and manufacturing organisations, distributors and regulatory experts from across the region. Under the new partnership, the exhibition will also function as the annual marketplace for the Indo–CIS health trade corridor.
Beyond trade deals, the corridor’s agenda includes regulatory harmonisation, digitalisation of supply chains, investment facilitation and joint research opportunities. Nutrify today plans to deploy AI-driven regulatory intelligence tools to support compliance and cross-border nutraceutical trade.
The ministry of health of the Republic of Uzbekistan first deputy minister of health and chairman of pharmaceutical industry development agency Abdulla Azizov said Ubekistan is well positioned to act as a strategic bridge between India and the CIS region while building a transparent, technology-enabled trade ecosystem.
Nutrify today MTI executive director Khasim said the initiative connects global leadership dialogue in Mumbai with a structured commercial platform in Tashkent, helping translate strategic discussions into executable trade architecture.
Tricornio technologies vice president and pharma eurasia project director m. harikrishnan said the platform aims to create a long-term, policy-aligned ecosystem where innovation, compliance and cross-border healthcare trade can grow in a sustainable and scalable manner.
The ministry of health of the Republic of Uzbekistan chief international relations specialist Kamila Mirzaeva said the collaboration introduces digital tools and transparent frameworks into a more institutionalised trade architecture, while also encouraging joint ventures in manufacturing, technology transfer and regional expansion.
With demand for preventive health products rising globally, the new corridor could offer Indian manufacturers a fresh gateway into a fast-growing Eurasian market while reinforcing Uzbekistan’s ambition to become a regional pharmaceutical hub.
